| Cancer | Understanding the impact of cannabinoid 2 receptor modulation on HER2-positive tumour growth | Richard Grose | Barts Cancer Institute | 2023 | MRC iCASE |
| Cancer | Investigating how neutrophils modulate the immune response in the tumour microenvironment | Luigi Ombrato | Barts Cancer Institute | 2025 | MRC iCASE |
| Cancer | Understanding the role of Senescent Immune Cells in Breast Cancer Lung Metastasis | Luigi Ombrato | Barts Cancer Institute | 2024 | MRC-DTP |
| Cancer | Whole genome CRISPR screens to map genetic determinants of radionuclide therapy of cancer | Jane Sosabowski | Barts Cancer Institute | 2024 | MRC iCASE |
| Cancer | Characterising the metabolic requirements of the newly identified DC3 subset | Katiuscia Bianchi | Barts Cancer Institute | 2022 | MRC iCASE |
| Cancer | Combining c-MET inhibition with PARP inhibition in chemo-resistant HGSOC to overcome resistance | Stéphanie Kermorgant | Barts Cancer Institute | 2024 | MRC-DTP |
| Cancer | Understanding the T cell antigen presentation landscape in gastro-oesophageal cancers with oncogene amplification | Marco Gerlinger | Barts Cancer Institute | 2022 | MRC-DTP |
| Cancer | Signal Rewiring of the DNA Damage Pathway in Cancer | Tanya Soliman | Barts Cancer Institute | 2022 | MRC-DTP |
| Cancer/Bioinformatics | AI-Driven Multi-Omics Analysis for Biological Insights and Clinical Applications in Breast Cancer | Oscar Maiques | Barts Cancer Institute | 2025 | MRC iCASE |
| Cancer | Investigating and Targeting EGFR Heterogeneity in Glioblastoma | Paulo Baptista-Ribeiro | Barts Cancer Institute | 2023 | MRC iCASE |
| Cancer | Purification and characterization of micronuclei | Sarah McClelland | Barts Cancer Institute | 2022 | MRC iCASE |
| Cancer | Investigating aberrant sterol metabolism in renal cancer | Barrie Peck | Barts Cancer Institute | 2025 | MRC iCASE |
| Neurodegenerative Diseases | Determining glial contributions to tau pathology clearance | Cara Croft | Blizard | 2024 | MRC-DTP |
| Cancer Biology | Molecular mediators of cancer stem cell metastasis within a complex tumour microenvironment on a chip | Adrian Biddle | Blizard | 2025 | MRC-DTP |
| Cancer | Targeting RNA-based mechanisms as a new tool for anti-cancer therapies | Lovorka Stojic | Barts Cancer Institute | 2025 | MRC-DTP |
| Cancer | Interrogating the high grade serous ovarian cancer tumour microenvironment during the evolution of resistance to cancer drug therapy | Michelle Lockley | Barts Cancer Institute | 2023 | MRC-DTP |
| Cancer/Bioinformatics | Uncovering novel mechanisms of pro-senescence therapies for breast cancer using 3D models of the tumour microenvironment | Cleo Bishop | Blizard | 2025 | MRC-DTP |
| Cancer | Unveiling the contribution of plasma membrane dynamics to breast cancer chemoresistance mechanisms | Pedro Monteiro | Barts Cancer Institute | 2025 | MRC-DTP |
| Cancer | Dissecting cannabinoid receptor 2 signalling in HER2+ breast cancer | Richard Grose | Barts Cancer Institute | 2022 | MRC-DTP |
| Cancer | Cancer associated fibroblasts in squamous cancer: Coupling transcriptional heterogeneity with pathological matrix dynamics | Emanuel Rognoni | Blizard | 2023 | MRC-DTP |
| Cancer | Investigating rDNA dysregulation in cancer: Unraveling chromosomal rearrangements and breakage consequences on rDNA activity, ribosome biogenesis, and oncogenic transformation | Vardhman Rakyan | Blizard | 2023 | MRC-DTP |
| Immunity & Infection | Characterising host-pathogen interactions in haematopoietic stem cells isolated from blood & bone marrow of adults with latent tuberculosis infection | Adrian Martineau | Blizard | 2024 | MRC iCASE |
| Enteric Neurobiology | Clinical validation of a novel, nutritional treatment to induce weight loss in obese volunteers and Type 2 diabetic patients | Madusha Peiris | Blizard | 2023 | MRC iCASE |
| Immunity & Infection | Investigating the Mechanisms of Autoimmunity induced by Epstein-Barr Virus in Early Multiple Sclerosis | Angray Kang | Institute of Dentistry | 2022 | MRC-DTP |
| Cancer | Understanding and exploiting lipid metabolism in aggressive breast cancers | Barrie Peck | Barts Cancer Institute | 2024 | MRC-DTP |
| Neurodegenerative diseases | Exploring the links between dementia and cardiovascular diseases: causal interference and early detection | Petroula Proitsi | Wolfson Institute | 2023 | MRC-DTP |
| Neurophysiology | Defining the role of the Duffy gene in prostate cancer, pain and response to ADC therapy | Shafaq Sikandar | William Harvey Research Institute | 2026 | MRC iCASE |
| Cancer | Investigating the role of Pole and Mismatch Repair in sensitization to immune checkpoint inhibitors | Roberto Bellelli | Barts Cancer Institute | 2026 | MRC iCASE |
